Replies to post #63628 on Biotech Values

[rstor1]

the market for buying and selling drugs and drug companies is generally quite efficient.

Isn't part of the requirement for an efficient market that there be sufficient liquidity? If so, a market in drug companies has few sellers and even fewer buyers.

I would argue that this is an even more inefficient market.

Regards,
Bob

[alertmeipp]

>market for buying and selling drugs and drug companies is generally quite efficient.

But the hard part is to figure out what is the efficient price.